Abstract
Background: The determinants of successful humoral immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of critical importance for the design of effective vaccines and the evaluation of the degree of protective immunity conferred by exposure to the virus. As novel variants emerge, understanding their likelihood of suppression by population antibody repertoires has become increasingly important.
Methods: In this study, we analyzed the SARS-CoV-2 polyclonal antibody response in a large population of clinically well-characterized patients after mild and severe COVID-19 using a panel of microarrayed structurally folded and unfolded SARS-CoV-2 proteins, as well as sequential peptides, spanning the surface spike protein (S) and the receptor-binding domain (RBD) of the virus.
Results: S- and RBD-specific antibody responses were dominated by immunoglobulin G (IgG), mainly IgG 1 , and directed against structurally folded S and RBD and three distinct peptide epitopes in S2. The virus neutralization activity of patients´ sera was highly correlated with IgG antibodies specific for conformational but not sequential RBD epitopes and their ability to prevent RBD binding to its human receptor angiotensin-converting enzyme 2 (ACE2). Twenty percent of patients selectively lacked RBD-specific IgG. Only immunization with folded, but not with unfolded RBD, induced antibodies against conformational epitopes with high virus-neutralizing activity. Conformational RBD epitopes required for protection do not seem to be altered in the currently emerging virus variants.
Conclusion: These results are fundamental for estimating the protective activity of antibody responses after natural infection or vaccination and for the design of vaccines, which can induce high levels of SARS-CoV-2-neutralizing antibodies conferring sterilizing immunity.
Keywords: COVID-19; SARS-CoV-2; conformational epitopes; vaccine; virus neutralization.
【저자키워드】 COVID-19, SARS-CoV-2, Vaccine, virus neutralization., conformational epitopes, 【초록키워드】 IgG, ACE2, coronavirus, vaccination, severe COVID-19, Immunity, Vaccines, Neutralizing antibodies, antibody, Antibody Response, variant, peptide, severe acute respiratory syndrome Coronavirus, virus, angiotensin-converting enzyme 2, immunization, Spike protein, Epitopes, Antibody responses, Immunoglobulin G, IgG antibody, Receptor-binding domain, Immunoglobulin, IgG antibodies, protective immunity, RBD, sterilizing immunity, sera, Patient, Virus neutralization, peptides, Mild, humoral immune response, virus variants, receptor, determinants, respiratory, natural infection, epitope, Critical, Protective, conformational epitopes, SARS-CoV-2-neutralizing antibodies, Angiotensin-converting enzyme, angiotensin, SARS-CoV-2 proteins, antibody repertoire, exposure to, polyclonal antibody, determinant, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, suppression, Effective vaccines, RBD binding, RBD-specific IgG, peptide epitopes, Prevent, polyclonal, likelihood, analyzed, clinically, required, correlated, the receptor-binding domain, conformational, induce, effective vaccine, virus-neutralizing, increasingly, peptide epitope, SARS-CoV-2-neutralizing antibody, the SARS-CoV-2, 【제목키워드】 antibody, epitope, domain, conformational,